Insight into Drug Distribution and Local Concentration using Multispectral Imaging of Fluorescent Drugs in Inflammatory Bowel Diseases

Informazioni relative al progetto

msGUIDE

ID dell’accordo di sovvenzione: 101046923

DOI

10.3030/101046923

Data della firma CE 22 Marzo 2022

Data di avvio 1 Aprile 2022

Data di completamento 31 Marzo 2027

Finanziato da

• The European Innovation Council (EIC)

Costo totale

€ 4 027 965,00

Contributo UE

€ 4 027 964,75

Coordinato da

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Germany

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Websites, patent fillings, videos etc. (1)

msGUIDE virtual identity

A functional website with a private area and social media accounts will be created as well as design and creation of the projects logo

Documents, reports (2)

Data management plan

Report on the data management strategy all along the project in line with the FAIR and Open Data Principles The first DMP is esxpected at M6 as the consortium will be part of the Open Research Data Pilot

Plan for dissemination and exploitation including communication activities

A multiannual dissemination strategy targeting different audiences will be created and the exploitation plan will be prepared

Pubblicazioni

Peer reviewed articles (6)

Impact of signal-to-noise ratio and contrast definition on the sensitivity assessment and benchmarking of fluorescence molecular imaging systems

Autori: Elena Kriukova, Ethan LaRochelle, T. Joshua Pfefer, Udayakumar Kanniyappan, Sylvain Gioux, Brian Pogue, Vasilis Ntziachristos, and Dimitris Gorpas
Pubblicato in: J. Biomed. Opt., 2024, ISSN 1083-3668
Editore: S P I E - International Society for Optical Engineering
DOI: 10.1117/1.JBO.30.S1.S13703

Reflect: reporting guidelines for preclinical, translational and clinical fluorescence molecular imaging studies

Autori: Bas Keizers, Marcus C. M. Stroet, Meedie Ali, Sam Floru, Jelena Saliën, Laura Mezzanotte, Edward J. Delikatny, Summer L. Gibbs, Stefano Giuliani, Sylvain Gioux, Hans Ingelberts, Schelto Kruijff, Vasi
Pubblicato in: npj Imaging, Numero 3, 2025, ISSN 2948-197X
Editore: Springer Science and Business Media LLC
DOI: 10.1038/S44303-025-00125-8

Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept

Autori: Henrik K. Huizinga, Rosalie J. van Dijken, Bahez Gareb, Bart G.J. Dekkers, Jacoba van Zanten, Hans H. Westra, Pauline Koopmans, Wouter B. Nagengast, Marjolijn N. Lub-de Hooge
Pubblicato in: International Journal of Pharmaceutics: X, Numero 11, 2026, ISSN 2590-1567
Editore: Elsevier BV
DOI: 10.1016/J.IJPX.2026.100514

Performance Assessment and Quality Control of Fluorescence Molecular Endoscopy With a Multi-Parametric Rigid Standard

Autori: Anna Tenditnaya; Ruben Y. Gabriëls; Wouter T.R. Hooghiemstra; Uwe Klemm; Wouter B. Nagengast; Vasilis Ntziachristos
Pubblicato in: IEEE Transactions on Medical Imaging, 2024, ISSN 0278-0062
Editore: IEEE
DOI: 10.1109/TMI.2024.3398816

Real-time fidelity assessment of fluorescence molecular imaging without reference images

Autori: Elena Kriukova, Sarah Glasl, Vasilis Ntziachristos, Dimitris Gorpas
Pubblicato in: Journal of Biomedical Optics, Numero 31, 2026, ISSN 1083-3668
Editore: SPIE-Intl Soc Optical Eng
DOI: 10.1117/1.JBO.31.6.066001

Biomedical Optics Express

Autori: Augusto Arias; Maria Anastasopoulou; Dimitris Gorpas; Vasilis Ntziachristos
Pubblicato in: Biomedical Optics Express, 2023, ISSN 2156-7085
Editore: The Optical Society
DOI: 10.1364/BOE.496599

Conference proceedings (1)

Multiparametric standards for performance assessment and quality control of fluorescence molecular imaging and endoscopy systems

Autori: Dimitris Gorpas, Vasilis Ntziachristos
Pubblicato in: Design and Quality for Biomedical Technologies XVIII, 2025
Editore: SPIE
DOI: 10.1117/12.3041715